Osteoporosis

BMD in Menopause Improved With OSA-Related Hypoxia

BMD in Menopause Improved With OSA-Related Hypoxia

By

The risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

By

Risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Do Depression, Anxiety Affect BMD in Anorexia?

Do Depression, Anxiety Affect BMD in Anorexia?

By

Anxiety and depression are associated with low BMD in anorexia patients.

Relationship of BMD and Physical Activity in Class III Obesity

Relationship of BMD and Physical Activity in Class III Obesity

By

In people with class III obesity, variance in femoral neck BMD can be determined by time spent doing light physical activity.

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

By

Following adjustment, fracture risk was highest among patients in the lowest osteoprotegerin levels.

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

By

To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

By

K-Postn may serve as a predictor of incident low-trauma fractures in postmenopausal women.

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow fat may determine bone mass after Roux-en-Y gastric bypass.

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

By

Discontinuing denosumab therapy in osteoporosis may increase the risk for vertebral fractures.

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

By

Romosozumab could be a better option than teriparatide for patients at a high risk for fracture.

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

By

Fracture risk is able to be predicted as long as 25 years by a single BMD and fracture history assessment.

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis medications are increasing BMD in men with nonmetastatic prostate cancer who are receiving ADT.

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

By

The clinical benefits of beginning ART early outweigh the decrease outcomes related to bone mineral density.

Osteoporosis Tx Romosozumab Continues License Application

Osteoporosis Tx Romosozumab Continues License Application

By

The FDA has published a Complete Response Letter in reply to the BLA for romosozumab.

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Scientific evidence should be considered in optimal management of coexisting T2D and osteoporosis.

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

By

Alendronate treatment was associated with a significantly lower risk for hip fracture among older patients.

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

By

Approval was based on the results of the ACTIVE and ACTIVExtension trials.

Osteoporosis More Likely in Multiple Sclerosis

Osteoporosis More Likely in Multiple Sclerosis

By

Osteoporosis was more prevalent in patients with MS compared with matched controls.

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

By

Bone mineral density was statistically different from baseline after 24 months.

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

By

Bone ultrasonography was able to detect tenofovir-induced bone loss in patients with HIV.

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

By

Case study of an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

By

This study shows that populations exposed to more cadmium in their diet were at a disproportionately increased risk of developing osteoporosis.

Low Level of Physical Activity May Cut Fracture Risk

Low Level of Physical Activity May Cut Fracture Risk

There was a lower rate of fracture for individuals who walked or bicycled less than 20 minutes/day vs hardly ever.

Testosterone Treatment Increases Bone Density, Strength in Older Men

Testosterone Treatment Increases Bone Density, Strength in Older Men

By

Testosterone replacement therapy may help improve bone mineral density and strength in older men.

Osteoporosis Treatment Receives Updated Guidelines From ACP

Osteoporosis Treatment Receives Updated Guidelines From ACP

By

The American College of Physicians has updated its 2008 guidelines on treating low bone density and osteoporosis to prevent fractures.

Updated UK Clinical Guidelines for Osteoporosis Emphasize Risk Assessment and Prevention

Updated UK Clinical Guidelines for Osteoporosis Emphasize Risk Assessment and Prevention

By

The UK National Osteoporosis Guideline Group released updated guidelines for the prevention of fragility fracture in postmenopausal women and in men aged 50 years or older.

Less Frequent Bisphosphonate in Bone Metastases May Not Increase Fracture Risk

Less Frequent Bisphosphonate in Bone Metastases May Not Increase Fracture Risk

By

Less frequent dosing of zoledronic acid does not increase fracture risk in patients with bone metastases.

Osteoporosis Tx Increases Survival in Postmenopausal Breast Cancer

Osteoporosis Tx Increases Survival in Postmenopausal Breast Cancer

There was improved event-free survival and distant disease-free survival among postmenopausal breast cancer patients.

Fracture Risk Linked to Psychotropic Medication Use

Fracture Risk Linked to Psychotropic Medication Use

By

Hip fracture and risk of major osteoporotic fracture were associated with psychotropic medication use.

Tuberculosis Increases Osteoporosis, Osteoporotic Fracture Risk

Tuberculosis Increases Osteoporosis, Osteoporotic Fracture Risk

By

Patients with a history of tuberculosis are at higher risk for developing osteoporosis or osteoporotic fractures.

Sign Up for Free e-newsletters